APA (7th ed.) Citation

Jameson, G. S., Hosein, P. J., Pierce, E., Kamgar, M., Gordon, M. S., Snyder, C., . . . Borazanci, E. (2024). Phase II clinical trial of nab‐paclitaxel plus cisplatin plus gemcitabine (NABPLAGEM) in patients with untreated advanced pancreatic cancer. Cancer Medicine, 13(12), 1. https://doi.org/10.1002/cam4.7412

Chicago Style (17th ed.) Citation

Jameson, Gayle S., et al. "Phase II Clinical Trial of Nab‐paclitaxel Plus Cisplatin Plus Gemcitabine (NABPLAGEM) in Patients with Untreated Advanced Pancreatic Cancer." Cancer Medicine 13, no. 12 (2024): 1. https://doi.org/10.1002/cam4.7412.

MLA (9th ed.) Citation

Jameson, Gayle S., et al. "Phase II Clinical Trial of Nab‐paclitaxel Plus Cisplatin Plus Gemcitabine (NABPLAGEM) in Patients with Untreated Advanced Pancreatic Cancer." Cancer Medicine, vol. 13, no. 12, 2024, p. 1, https://doi.org/10.1002/cam4.7412.